Tag Archives: ACLU

Supreme Court Rules In Myriad On Patentability Of DNA

Today, the Supreme Court ruled that a naturally occurring DNA sequence is a product of nature, and not patent-eligible simply because it has been “isolated.” (A copy of the ruling can be found at the end of this post.) However, the … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , | 4 Comments

AMP Petitions for Cert. and A Look Back

The Association for Molecular Pathology (AMP) has petitioned the Supreme Court to review the Fed. Cir.’s opinion of July 29th, that isolated BRCA DNA sequences are patentable subject matter. Its brief (a copy available at the end of this post) … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , , , , , , , , | 1 Comment

AMC v. Myriad – “Laws of Nature” Exception Does Not Include Isolated DNA

As noted in my last “flash” post, a divided three-judge Fed. Cir. panel (Judges Lourie, Bryson and Moore) issued an opinion holding that the isolated DNA sequences and the drug-screening method claimed by Myriad are patentable subject matter, not natural … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , , , , , | 2 Comments

AUTM Panel To Address A “Myriad” Of Challenges

Robert S. MacWright, J.D., Ph.D., the new head of tech transfer at the Salk Institute, will moderate a panel at the 2011 Annual Meeting of the Association of University Technology Managers (AUTM) on March 1st in Las Vegas.  The panel, … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , , , , , , , | Leave a comment